Ileostomy Observation Study
Assessment of Bone Mineral Density, Vitamin D Status and Calcium Intakes in Ileostomy Patients.
1 other identifier
observational
200
1 country
1
Brief Summary
Inflammatory bowel disease (IBD) which is associated with low bone mineral density is divided into 2 major disease entities: Crohn's disease and ulcerative colitis. Medical therapy is directed at controlling symptoms and reducing the underlying inflammatory process. Studies have reported that 60% of patients with Crohn's disease and 15%-30% of patients with ulcerative colitis require surgical intervention for the management of their disease. In the United Kingdom almost 13,000 ileostomy procedures are undertaken annually. A 29.4% prevalence of low bone mineral density (BMD) was reported in a cohort of US patients with IBD and ileostomy who were \>5 years postoperative. Possible risk factors for bone loss in patients with IBD and ileostomy are considered to include malabsorption secondary to bowel resection, malnutrition and more aggressive disease and inflammation which led to bowel resection in the first place . These factors also contribute to reduced intestinal absorption of nutrients and vitamins including B \& D subsequently leading to potential health complications including low BMI and low lean body mass. It has been reported that IBD patients who have surgical intervention to create ileal pouches also have low levels of vitamin D. Surgical procedures such as an ileostomy alter the normal anatomy and physiology of the small intestine. Bile acid (BA) malabsorption which is common to IBD is caused by impaired conjugated BA reabsorption and a consequence, numerous pathological sequelae may occur, including the malfunction of lipid digestion . Further, bacterial overgrowth can lead to deconjugation of bile salts, leading to formation of free bile acids, again inducing dietary fat malabsorption, which in turn can lead to vitamin D deficiency. As vitamin D is a fat-soluble vitamin, malfunction of lipid digestion or absorption is problematic. Given the paucity of data in the area of ileostomy patients BMD, vitamin D status and calcium intake, we will establish baseline observations within the Northern Ireland (NI) population with an observational study to assess bone mineral density (Dexa), collecting ileal fluid and plasma samples assessing vitamin D status, calcium, dietary intake and other measures including questionnaires on quality of life and exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 10, 2017
CompletedFirst Submitted
Initial submission to the registry
October 7, 2019
CompletedFirst Posted
Study publicly available on registry
October 29, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2020
CompletedJune 18, 2020
June 1, 2020
3.2 years
October 7, 2019
June 16, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bone Density
Dual Energy X-ray Absorptiometry (DXA)
1 day, 1 measurement
Secondary Outcomes (11)
Total serum 25-hydroxyvitamin D [25(OH)D] commercial kit)
1 day, 1 measurement
Parathyroid hormone concentrations commercial kit)
1 day, 1 measurement
Serum adjusted calcium
1 day, 1 measurement
Lipid profile
1 day, 1 measurement
Plasma glucose
1 day, 1 measurement
- +6 more secondary outcomes
Eligibility Criteria
Ileostomy patients
You may qualify if:
- undergone an ileostomy and be more than 2 year post-operative
- non smoking
You may not qualify if:
- not undergone an ileostomy and/or is less than 2 year post-operative
- smoker.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Ulsterlead
- University of Naplescollaborator
Study Sites (1)
Human Intervention Studies Unit, Ulster University
Coleraine, Co.Londonderry, BT52 1SA, United Kingdom
Related Publications (1)
Tagliamonte S, Gill CIR, Pourshahidi LK, Slevin MM, Price RK, Ferracane R, Lawther R, O'Connor G, Vitaglione P. Endocannabinoids, endocannabinoid-like molecules and their precursors in human small intestinal lumen and plasma: does diet affect them? Eur J Nutr. 2021 Jun;60(4):2203-2215. doi: 10.1007/s00394-020-02398-8. Epub 2020 Oct 26.
PMID: 33104865DERIVED
Biospecimen
Ileal fluid Blood samples - plasma, serum, whole blood, red cells and buffy coat retained.
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 7, 2019
First Posted
October 29, 2019
Study Start
July 10, 2017
Primary Completion
October 1, 2020
Study Completion
October 1, 2020
Last Updated
June 18, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share